Memantine in the treatment of binge eating disorder: an open-label, prospective trial.

Objective: To assess preliminarily the efficacy of memantine in binge eating disorder.

Method: This was an open-label, 12-week, flexible-dose (5-20 mg/day) trial of memantine in binge eating disorder. The primary outcome was frequency of binge days.